RTI Surgical, Inc. (NASDAQ:RTIX)
Industry: Healthcare

RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

Current Quote*
Last: $4.440
Change: -0.080
Book: $1.635
Volume: 33,738

As Of: 11/14 14:41 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol RTIX

Graphs for RTIX


3 Month Graph


6 Month Graph


1 Year Graph